Search

Coloplast A-S (Class B)

Fermé

552.6 1.02

Résumé

Variation du prix de l'action

24h

Actuel

Min

541.2

Max

558

Chiffres clés

By Trading Economics

Revenu

70M

875M

Ventes

2M

7B

P/E

Moyenne du Secteur

33.486

89.037

BPA

3.88

Rendement du dividende

4.24

Marge bénéficiaire

12.572

Employés

16,744

EBITDA

2B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.24%

2.18%

Prochains Résultats

6 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-947M

122B

Ouverture précédente

551.58

Clôture précédente

552.6

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 janv. 2026, 23:49 UTC

Principaux Mouvements du Marché

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21 janv. 2026, 21:12 UTC

Principaux Mouvements du Marché

Automaker Stocks Rise After Trump Calls Off European Tariffs

21 janv. 2026, 21:00 UTC

Acquisitions, Fusions, Rachats

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21 janv. 2026, 20:29 UTC

Principaux Mouvements du Marché

Chip Makers Gain After Trump Calls Off European Tariffs

21 janv. 2026, 20:04 UTC

Principaux Mouvements du Marché

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21 janv. 2026, 23:34 UTC

Market Talk

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21 janv. 2026, 22:39 UTC

Résultats

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21 janv. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

21 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 janv. 2026, 21:35 UTC

Acquisitions, Fusions, Rachats

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21 janv. 2026, 21:19 UTC

Résultats

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21 janv. 2026, 20:45 UTC

Acquisitions, Fusions, Rachats

Deutsche Borse Group to Acquire Allfunds for $6.19B

21 janv. 2026, 20:36 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21 janv. 2026, 20:31 UTC

Market Talk

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21 janv. 2026, 20:27 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21 janv. 2026, 20:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 janv. 2026, 20:27 UTC

Market Talk

Was It a 'TACO' Event? -- Market Talk

21 janv. 2026, 20:26 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21 janv. 2026, 20:23 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21 janv. 2026, 20:21 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21 janv. 2026, 20:19 UTC

Acquisitions, Fusions, Rachats

Deutsche Boerse Group Agrees to Buy Allfunds

21 janv. 2026, 20:08 UTC

Résultats

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21 janv. 2026, 20:03 UTC

Market Talk

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21 janv. 2026, 19:51 UTC

Market Talk

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21 janv. 2026, 19:43 UTC

Market Talk

U.S. Ethanol Production Expected to Slip -- Market Talk

21 janv. 2026, 19:31 UTC

Market Talk

Gold Settles at Fresh All-Time High -- Market Talk

21 janv. 2026, 19:24 UTC

Résultats

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21 janv. 2026, 19:10 UTC

Market Talk

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21 janv. 2026, 18:57 UTC

Market Talk

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat